A carregar...
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas
The response of patients with gliomas to alkylating chemotherapy is heterogeneous. However, there are currently no universally accepted predictors of patient response to these agents. We identify the nuclear factor κB (NF-κB) co-regulator B cell CLL/lymphoma 3 (BCL-3) as an independent predictor of...
Na minha lista:
| Publicado no: | Sci Transl Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6613219/ https://ncbi.nlm.nih.gov/pubmed/29973405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aar2238 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|